Rex Haydon, MD, PhD, focuses on the comprehensive treatment of malignant and benign tumors in bone or soft tissue. He specializes in the surgical care of bone and soft tissue tumors, including limb-salvage and reconstructive surgery of the upper and lower extremities. Dr. Haydon works with an integrated team of specialists to ensure that patients have access to the most innovative and effective treatment options available.
Also a skilled physician scientist, his research focuses on advancing the treatment of musculoskeletal tumors. Dr. Haydon has a particular interest in the underlying causes of musculoskeletal neoplasms. Author of more than 25 articles and book chapters, he has accepted career development awards from both the Orthopaedic Research and Education Foundation and the National Institutes of Health. Additionally, Dr. Haydon's research has been supported by the Musculoskeletal Tumor Foundation.
The University of Chicago
Chicago, Illinois
Orthopaedic Fellowship - Oncology
2003
The University of Chicago
Chicago, Illinois
Orthopaedic Fellowship - Research
2002
The University of Chicago
Chicago, Illinois
Resident - Orthopaedic Surgery
2001
The University of Chicago
Chicago, Illinois
Ph.D - Anthropology
1996
The University of Chicago
Chicago, Illinois
M.A. - MAPSS (Social Sciences),
1993
The University of Chicago
Chicago, Illinois
B.A. - Anthropology
1988
Correction: BMP9-regulated angiogenic signaling plays an important role in the osteogenic differentiation of mesenchymal progenitor cells.
Correction: BMP9-regulated angiogenic signaling plays an important role in the osteogenic differentiation of mesenchymal progenitor cells. J Cell Sci. 2023 Jun 01; 136(11).
PMID: 37272422
Bone Morphogenic Protein 9 (BMP9)/Growth Differentiation Factor 2 (GDF2) modulates mouse adult hippocampal neurogenesis by regulating the survival of early neural progenitors.
Bone Morphogenic Protein 9 (BMP9)/Growth Differentiation Factor 2 (GDF2) modulates mouse adult hippocampal neurogenesis by regulating the survival of early neural progenitors. Genes Dis. 2023 Jul; 10(4):1175-1179.
PMID: 37397531
Canonical and noncanonical Wnt signaling: Multilayered mediators, signaling mechanisms and major signaling crosstalk.
Canonical and noncanonical Wnt signaling: Multilayered mediators, signaling mechanisms and major signaling crosstalk. Genes Dis. 2024 Jan; 11(1):103-134.
PMID: 37588235
Long noncoding RNA (lncRNA) H19: An essential developmental regulator with expanding roles in cancer, stem cell differentiation, and metabolic diseases.
Long noncoding RNA (lncRNA) H19: An essential developmental regulator with expanding roles in cancer, stem cell differentiation, and metabolic diseases. Genes Dis. 2023 Jul; 10(4):1351-1366.
PMID: 37397543
Corrigendum to "Characterization of the essential role of bone morphogenetic protein 9 (BMP9) in osteogenic differentiation of mesenchymal stem cells (MSCs) through RNA interference" [Genes & Diseases 5(2018):172-184].
Corrigendum to "Characterization of the essential role of bone morphogenetic protein 9 (BMP9) in osteogenic differentiation of mesenchymal stem cells (MSCs) through RNA interference" [Genes & Diseases 5(2018):172-184]. Genes Dis. 2023 Mar; 10(2):632-637.
PMID: 37223525
Corrigendum to 'Modeling colorectal tumorigenesis using the organoids derived from conditionally immortalized mouse intestinal crypt cells (ciMICs)' [Genes Dis 8 (2021) 814-826].
Corrigendum to 'Modeling colorectal tumorigenesis using the organoids derived from conditionally immortalized mouse intestinal crypt cells (ciMICs)' [Genes Dis 8 (2021) 814-826]. Genes Dis. 2023 Mar; 10(2):618-619.
PMID: 37223499
Corrigendum to "The development of a sensitive fluorescent protein-based transcript reporter for high throughput screening of negative modulators of lncRNAs" [Genes & Diseases 5 (2018) 62-74].
Corrigendum to "The development of a sensitive fluorescent protein-based transcript reporter for high throughput screening of negative modulators of lncRNAs" [Genes & Diseases 5 (2018) 62-74]. Genes Dis. 2023 Mar; 10(2):627-629.
PMID: 37223508
Corrigendum to "Establishment and functional characterization of the reversibly immortalized mouse glomerular podocytes (imPODs)" [Genes & Diseases 5 (2018) 137-149].
Corrigendum to "Establishment and functional characterization of the reversibly immortalized mouse glomerular podocytes (imPODs)" [Genes & Diseases 5 (2018) 137-149]. Genes Dis. 2023 Mar; 10(2):630-631.
PMID: 37223498
Niclosamide (NA) overcomes cisplatin resistance in human ovarian cancer.
Niclosamide (NA) overcomes cisplatin resistance in human ovarian cancer. Genes Dis. 2023 Jul; 10(4):1687-1701.
PMID: 37397523
SV40 large T antigen-induced immortalization reprograms mouse cardiomyocyte progenitors with mesenchymal stem cell characteristics and osteogenic potential.
SV40 large T antigen-induced immortalization reprograms mouse cardiomyocyte progenitors with mesenchymal stem cell characteristics and osteogenic potential. Genes Dis. 2023 Jul; 10(4):1161-1164.
PMID: 37397535
Orlov Visiting Professor in Orthopaedic Oncology
Loyola University of Chicago
2018
Senior Faculty Scholar
Bucksbaum Institute for Clinical Excellence
2017
Gerald S. Laros Resident Teaching Award
2011
Keynote Speaker
Pritzker School of Medicine White Coat Ceremony
2010
American-British-Canadian Traveling Fellowship, AOA
2009
Induction into ??? (Beta Chapter) as Faculty member by Pritzker School of Medicine
2008
Gerald S. Laros Resident Teaching Award
2007
Orthopaedic Research Society Career Development Award
2006
Kappa Delta Ann Doner Vaughan Award, Co-Recipient, AAOS/ORS
2006
Marshall R. Urist Young Investigator Award, Association of Bone & Joint Surgeons
2006
John J. Fahey, MD Memorial North American Traveling Fellowship, AOA
2005
K08 Mentored Clinical Scientist Development Award, NIH-NIAMS
2004 - 2009
Thomas M. Coffman OREF Career Development Award
2003 - 2005
Best Poster Award: Charles Huggins Conference: “Upregulation Of cKit In Giant Cell Tumor of Bone: Po
2002
Howard Schneider Award for Best Manuscript at the OREF Midwest Conference
2000